SUTRO BIOPHARMA, INC. Quarterly Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent in pure from Q1 2022 to Q2 2023
-
Taxonomy & unit
-
us-gaap: pure
-
Description
-
Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
-
Summary
-
Sutro Biopharma, Inc. annual/quarterly Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent history and growth rate from Q1 2022 to Q2 2023.
- Sutro Biopharma, Inc. Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for the quarter ending June 30, 2023 was 0.21 pure.
- Sutro Biopharma, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2023 was 0.21 pure, unchanged from 2022.
- Sutro Biopharma, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2022 was 0.21 pure, unchanged from 2021.
- Sutro Biopharma, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2021 was 0.21 pure, unchanged from 2020.
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, Quarterly (pure)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, YoY Quarterly Growth (%)